0000000000078292

AUTHOR

Marco Romano

showing 2 related works from this author

Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in I…

2021

Background: Information on the management of Helicobacter (H.) pylori infection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment of H. pylori infection in Italy. Materials and Methods: All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases - FISMAD were invited to fill-in an on-line questionnaire. The questionnaire included questions on the diagnosis and treatment of H. pylori infection. Results: A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the stu…

Background informationHelicobacter pylori infectionmedicine.medical_specialtygenetic structuresdiagnosisgastroenterology fellowGastroenterologyHelicobacter pylori; diagnosis; gastroenterologists; gastroenterology fellows; guidelines; treatment; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy Combination; Humans; Proton Pump Inhibitors; Surveys and Questionnaires; Gastroenterologists; Gastroenterology; Helicobacter Infections; Helicobacter pyloriHelicobacter InfectionsDrug TherapyClarithromycinInternal medicineClarithromycinSurveys and QuestionnairesMedicineHumansguidelinesbiologyHelicobacter pyloritreatmentbusiness.industryGastroenterologistsGastroenterologyAmoxicillinProton Pump InhibitorsGeneral MedicineHelicobacter pyloribiology.organism_classificationeye diseasesAnti-Bacterial AgentsdiagnosiInfectious Diseasesgastroenterology fellowsThird lineCombinationDrug Therapy CombinationgastroenterologistEducational interventionsbusinessguidelineBismuthmedicine.drug
researchProduct

Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells

2015

Immunosuppressive drugs in clinical transplantation are necessary to inhibit the immune response to donor antigens. Although they are effective in controlling acute rejection, they do not prevent long-term transplant loss from chronic rejection. In addition, immunosuppressive drugs have adverse side effects, including increased rate of infections and malignancies. Adoptive cell therapy with human Tregs represents a promising strategy for the induction of transplantation tolerance. Phase I/II clinical trials in transplanted patients are already underway, involving the infusion of Tregs alongside concurrent immunosuppressive drugs. However, it remains to be determined whether the presence of …

Male0301 basic medicineAdoptive cell transferchemical and pharmacologic phenomenaPharmacologyBiologyT-Lymphocytes RegulatoryArticleCell therapyImmunosuppressive AgentMice03 medical and health sciences0302 clinical medicineImmune systemIn vivoAnimalsHumansCells CulturedMice KnockoutMice Inbred BALB CAnimalHematologyAdoptive TransferTacrolimusInterleukin-10TransplantationSettore MED/16 - Reumatologia030104 developmental biologyGene Expression RegulationHumanized mouseImmunologyFemaleReceptors ChemokineImmunosuppressive AgentsEx vivoHuman030215 immunologyHaematologica
researchProduct